Pearson's Pharmacy, Inc. v. Express Scripts, Inc.

505 F. Supp. 2d 1272, 2007 U.S. Dist. LEXIS 41755, 2007 WL 1655993
CourtDistrict Court, M.D. Alabama
DecidedJune 7, 2007
Docket3:06-cv-73-WKW
StatusPublished
Cited by10 cases

This text of 505 F. Supp. 2d 1272 (Pearson's Pharmacy, Inc. v. Express Scripts, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pearson's Pharmacy, Inc. v. Express Scripts, Inc., 505 F. Supp. 2d 1272, 2007 U.S. Dist. LEXIS 41755, 2007 WL 1655993 (M.D. Ala. 2007).

Opinion

*1274 MEMORANDUM OPINION AND ORDER

WATKINS, District Judge.

Before the court is defendant Express Scripts, Inc.’s (“ESI”) Motion to Dismiss (Doc. #8). For the reasons that follow, defendant’s motion is due to be GRANTED.

I. FACTS AND PROCEDURAL HISTORY

Pearson’s Pharmacy, Inc. (“Pearson’s”), and CAM Enterprises, Inc., d/b/a Altadena Pharmacy (“CAM”), brought suit against ESI alleging (1) fraud; (2) breach of contract; (3) unjust enrichment and constructive trust; and (4) the need for injunctive relief. Pearson’s and CAM are pharmacies, and ESI is a pharmacy benefit management company. ESI contracts with pharmacies, as a representative of third party payors, to reimburse the cost of prescription medications sold by the pharmacies. At a time unknown, the parties entered into a contract in which ESI would reimburse the plaintiffs for prescription medications based upon an Average Wholesale Price (“AWP”). 1

“AWP[, according to plaintiffs,] is the average of the prices charged by national drug wholesalers for a given prescription drug.” (Am.Compl^ 9.) Plaintiffs contend that AWP is “readily ascertainable and easily definable----[having been published in] Red Book, Blue Book and Medis-pan,” as well as being reported to all interested parties. Id. The bottom line of plaintiffs’ breach of contract allegation is that ESI “deliberately refuses to fully reimburse [them] at AWP according to the terms of the contract.” Id. Plaintiffs also allege that ESI never intended to abide by the contract, intentionally misled plaintiffs as to the purpose of the program, and was under a duty not to misrepresent the program. Further, plaintiffs allege that they entered into the contract with the defendant based upon a misrepresentation by the defendant as to the pricing formula for AWP. Plaintiffs attempt to articulate the fraudulent misrepresentations and/or sup-pressions, both written and oral, in the following language of their complaint:

a. that Defendant would not fully, timely and properly reimburse Plaintiffs;
b. that Defendant would not reimburse Plaintiffs and putative class members according to the Average Wholesale Price (suppression);
c. that Defendant would reimburse Plaintiffs and putative class members according to the Average Wholesale Price (misrepresentation);
d. By suppressing and/or misrepresenting the facts alleged herein which constitutes engaging in a pattern and practice of untruthful statements, false representations, concealment, and intent to mislead in its contractual agreements;
e. By failing to disclose that Defendant either did not have access to or would not reimburse Plaintiffs and putative class members based upon the daily Average Wholesale Price;
f. By failing to disclose the method upon which Defendant would determine the Average Wholesale Price of a brand name prescription medication;
g. By failing to send Plaintiffs and other pharmacies enough information to make an informed decision regarding Defendant’[s] AWP reimbursement program;
*1275 h. By charging Plaintiffs an unconscionable fee and engaging in unconscionable practices.

(Id. ¶ 16.)

The court held oral argument on defendant’s motion to dismiss count I (fraud) and count III (unjust enrichment and constructive trust). During argument, plaintiffs conceded that their claims for injunc-tive relief and oral misrepresentation are to be dismissed without prejudice. Further, plaintiffs clarified their position that they are merely alleging a written misrepresentation in the contract as the only basis for their fraud and suppression claims. The defendants argued that, at best, plaintiffs can maintain only promissory fraud, rather than fraud arising from a term within the contract. The parties have fully briefed their respective positions on the instant motion.

II. STANDARD OF REVIEW

A Rule 12(b)(6) motion to dismiss tests the sufficiency of the complaint against the legal standard set forth in Rule 8: “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed.R.Civ.P. 8(a)(2). A complaint “requires more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do.” Bell Atl. Carp. v. Twombly, — U.S.-, 127 S.Ct. 1955, 1965, 167 L.Ed.2d 929 (2007) (citation omitted). Factual allegations in a complaint need not be detailed but “must be enough to raise a right to relief above the speculative level ... on the assumption that all the allegations in the complaint are true” (even if doubtful in fact). Id. at 1964-65 (citations omitted); see also Hill v. White, 321 F.3d 1334 (11th Cir.2003) (stating that the court accepts the allegations in the complaint as true and construes them in the light most favorable to the plaintiff). The court does “not require heightened fact pleading of specifics, but only enough facts to state a claim to relief that is plausible on its face.” Bell Atl., 127 S.Ct. at 1974.

III. DISCUSSION

Defendant moves for dismissal as to the plaintiffs’ fraud, suppression, and unjust enrichment and constructive trust claims. The court will address the issues in turn. First, with respect to plaintiffs’ claim of fraud, the ultimate issue for consideration is whether a written misrepresentation in a contract can give rise to fraud under Alabama law. The court finds that, in this situation, it does not. Second, the defendant did not owe a duty to disclose relevant facts to plaintiffs, which leaves plaintiffs’ suppression allegation without merit. Third, plaintiffs have a valid remedy at law for any alleged breach of contract requiring the dismissal of plaintiffs’ unjust enrichment and constructive trust claim.

A. Fraudulent Misrepresentations

During oral argument on defendant’s motion to dismiss, plaintiffs clarified to the court that the only misrepresentation they can point to with specificity is the allegedly ambiguous meaning of the term “AWP” in the contract. Defendant responds that fraud cannot arise solely out of a written misrepresentation in a contract and that, at best, plaintiffs are left with promissory fraud. The plaintiffs insist that they are not alleging promissory fraud. (Hr’g Tr. 37:3-4.) The court agrees with the defendant that an alleged written misrepresentation in a contract, without more, cannot be actionable as fraud in Alabama.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wiggins v. FDIC
N.D. Alabama, 2020
Madison Cnty. v. Evanston Ins. Co.
340 F. Supp. 3d 1232 (N.D. Alabama, 2018)
In re General Motors LLC Ignition Switch Litigation
257 F. Supp. 3d 372 (S.D. New York, 2017)
Univalor Trust, SA v. Columbia Petroleum, LLC
315 F.R.D. 374 (S.D. Alabama, 2016)
Cochran v. Five Points Temporaries, LLC
907 F. Supp. 2d 1260 (N.D. Alabama, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
505 F. Supp. 2d 1272, 2007 U.S. Dist. LEXIS 41755, 2007 WL 1655993, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pearsons-pharmacy-inc-v-express-scripts-inc-almd-2007.